Summary
The product Accutane 20 mg, submitted by MuscleCandy and identified by batch number Lot1001, underwent independent testing by Janoshik Analytical. The analysis measured the concentration of Isotretinoin, which was found to be 18.46 mg per capsule, slightly below the labeled claim of 20 mg.
The testing process began on 19 April 2024, with the sample received on 24 April 2024, and analysis completed on 26 April 2024. These results highlight the importance of independent verification to ensure accurate dosing. Continued scrutiny and comprehensive testing are essential for maintaining quality assurance in the pharmaceutical market.
Detailed Report
Product Overview
- Manufacturer: Unknown
- Product Name: Accutane 20 mg
- Active Ingredient: Isotretinoin
- Batch Number: Lot1001
- Expiration Date: Not provided
- Delivery Method: Oral capsule
Sample Acquisition and Testing
- Task Number: #41411
- Testing Ordered: 19 April 2024
- Sample Received: 24 April 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: MuscleCandy
- Analysis Paid For By: MuscleCandy
Testing Results
- Specification: 20 mg (as stated on the label)
- Measured Concentration: 18.46 mg
- Accuracy: 92.3% (7.7% below the label claim)
- Variance: -7.7%
Verification Details
- Verification URL: https://janoshik.com/tests/41411_88JCAYVJWGA3
Evaluation of Reseller-Submitted Testing
The analysis highlights a slight underdose for this batch of Accutane 20 mg capsules. As the testing was commissioned and submitted by the reseller MuscleCandy, it is important to approach the results with caution. Resellers may submit high-quality batches for testing, which may not fully represent product consistency across the market. Independent validation through testing multiple batches would provide a more comprehensive assessment.
Conclusion
The analysis confirms that the tested batch of Accutane 20 mg contains 18.46 mg of Isotretinoin, slightly below the labeled dosage. This result underscores the importance of third-party testing for quality assurance and informed decision-making regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
